跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 106,823 条关于
“papillary renal cancer”
全部
106,823
临床试验
87,676
药物
2,313
机构
1,129
资讯
15,705
去年
CALYPSO Trial: Savolitinib-Durvalumab Combo Shows Promising Results in MET-Driven Papillary Renal Cancer
去年
Cabozantinib Fails to Show Overall Survival Benefit in Papillary Renal Cell Carcinoma
去年
Bevacizumab-Erlotinib Combination Shows Remarkable 72% Response Rate in Rare HLRCC-Associated Kidney Cancer
去年
BRAF p.V600E Mutation Shows Limited Prognostic Value in Papillary Thyroid Cancer Risk Stratification
2年前
Lenvatinib and Pembrolizumab Combination Shows Promise in Non-Clear Cell Renal Cell Carcinoma Subtypes
2年前
IO/TKI Doublets Emerge as Standard of Care in Non-Clear Cell Renal Cell Carcinoma
2年前
Ipilimumab/Nivolumab Combo Improves Survival in Non-Clear Cell Renal Cell Carcinoma
去年
FDA Requests Additional Manufacturing Data for Telix's Kidney Cancer Diagnostic Drug Zircaix
去年
Real-World Data and Ongoing Trials Highlight Efficacy of Nadofaragene Firadenovec in Bladder Cancer
去年
FDA Approves Oncorena's IND for Novel Kidney-Specific Cancer Drug in Dialysis Patients
第 1 页,共 1571 页
上一页
下一页